The share price has rallied over the past month.

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new ...

The stock recently reached beyond $1,000.

Eli Lilly & Company (NYSE:LLY) ranks among the Best Low Volatility Investments in December 2025. Eli Lilly & Company ...

Eli Lilly’s stock has recently seen its consensus analyst price target rise from $1,003 to $1,024. This change reflects ...

A fresh call from Bernstein has Wall Street doing a double-take.

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Don't wait for a stock split to buy the stock, though.

The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that of its drugmaking peers.

Eli Lilly (NYSE: LLY) has outperformed the market over the past 5 years by 35.44% on an annualized basis producing an average annual return of 48.41%. Currently, Eli Lilly has a market capitalization ...

After a rough pullback, the major indices are attempting to rebound higher. Helping, not only is Bitcoin starting to rebound, ...

Eli Lilly stock (NYSE: LLY) should be on your radar. Here’s why – it is presently trading within the support range ($688 – $761), price points from which it has previously bounced significantly. Over ...